Emphysema

Emphysema Treatment

Emphysema treatment

Emphysema Treatment Available at the Lung Institute

There is not yet a cure for emphysema, so treatment typically focuses on managing symptoms through a combination of drugs, breathing exercises and supplemental oxygen. At the Lung Institute, we offer a breakthrough alternative treatment for emphysema and other types of chronic obstructive pulmonary disease (COPD), utilizing cells in an effort to potentially help improve lung function.

We specialize in cellular therapy, which uses the patient’s own cells to stimulate the body’s natural healing processes. For many people with emphysema, this advanced therapy may help them participate in the activities they enjoy while reducing common issues associated with lung problems, such as shortness of breath, coughing and wheezing. In fact, more than 80 percent of patients with COPD report an improved quality of life after receiving cellular therapy at the Lung Institute.

Our cellular therapy for emphysema is performed in an outpatient clinical setting over the course of two days. Our experienced physicians harvest cells through a simple blood draw in the arm. From there, the growth factor-rich cells are separated from other cells, processed in an onsite lab and intravenously returned to the patient’s body with the goal of reducing inflammation in the lungs and potentially slowing disease progression. Cells are a natural component of the body and not a drug, so most patients experience no adverse side effects after this form of emphysema treatment.

To take your first step toward learning if you are a candidate for emphysema treatment at the Lung Institute, contact our compassionate medical team today at (800) 729-3065. We’ll be glad to assist you in exploring alternative treatment options to help you breathe easier.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.